Cover Image
市場調查報告書

旋切術設備的全球市場的預測 ∼2022年:方向性、旋轉式、雷射、軌道性旋切術設備

Atherectomy Devices Market by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User (Hospitals, Surgical Centers, Ascs, Research Laboratories, Academic Institutes) - Global Forecasts To 2022

出版商 MarketsandMarkets 商品編碼 578842
出版日期 內容資訊 英文 151 Pages
訂單完成後即時交付
價格
Back to Top
旋切術設備的全球市場的預測 ∼2022年:方向性、旋轉式、雷射、軌道性旋切術設備 Atherectomy Devices Market by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User (Hospitals, Surgical Centers, Ascs, Research Laboratories, Academic Institutes) - Global Forecasts To 2022
出版日期: 2017年11月08日 內容資訊: 英文 151 Pages
簡介

全球旋切術設備的市場在預測期間內預計以6.1%的年複合成長率發展,從2017年的10億8000萬美元,到2022年成長到14億5000萬美元的規模。對象患者人口的增加,持續性的產品開發、商業化,醫療費償付上的優勢,最小侵入性動脈粥狀硬化斑塊切除術的需求擴大,主要製造商的銷售管道的強化等要素促進該市場的成長。

本報告提供全球旋切術設備的市場調查,市場及產品、技術概要,市場成長的影響因素及市場機會分析,研究開發平台分析,各產品、用途、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 市場成果、預測:各地區、產品
  • 地區分析:各用途
  • 亞太地區市場:各用途、各國
  • 地區市場變化、預測:各國

第5章 市場概要

  • 簡介
  • 市場動態
    • 推動要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 研究開發平台分析

第6章 市場分析:各產品

  • 簡介
  • 方向性旋切術設備
  • 軌道性旋切術設備
  • 光剝離 (雷射) 旋切術設備
  • 旋轉式旋切術設備
  • 支援設備

第7章 市場分析:各用途

  • 簡介
  • 末稍血管
  • 心血管
  • 神經血管

第8章 市場分析:各終端用戶

  • 簡介
  • 醫院、外科中心
  • 門診病人照護中心
  • 研究實驗室、學術機構

第9章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他地區

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭模式、趨勢
    • 產品的投入、強化
    • 協定、聯盟、合作
    • 擴張
    • M&A
    • 其他

第11章 企業簡介

  • 簡介
  • KONINKLIJKE PHILIPS
  • MEDTRONIC
  • CARDIOVASCULAR SYSTEMS
  • BOSTON SCIENTIFIC
  • C.R. BARD
  • CARDINAL HEALTH
  • MINNETRONIX, INC.
  • AVINGER
  • STRAUB MEDICAL
  • BIOMERICS
  • BIOTRONIK
  • RA MEDICAL SYSTEMS
  • Terumo Corporation
  • ABBOTT LABORATORIES
  • B. BRAUN GROUP

第12章 附錄

圖表

目錄
Product Code: MD 5717

The atherectomy devices market projected to grow at a CAGR of 6.1%

The global atherectomy devices market is projected to reach USD 1.45 billion by 2022 from USD 1.08 billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers. The increasing number of research activities in the field of atherectomy and rising healthcare expenditure across emerging markets are also driving the growth of the market. However, limited patient awareness related to disease diagnosis (resulting in delayed treatment for peripheral vascular diseases), stringent regulatory framework, dearth of well-trained surgeons to conduct atherectomy procedures, and significant adoption of alternative therapies are the key challenges faced by a majority of the atherectomy device manufacturers across the globe.

"The peripheral vascular applications segment is poised to be the fastest-growing during the forecast period."

On the basis of application, the global atherectomy devices market is segmented into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular atherectomy applications segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment, rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries, and growing patient preference for minimally invasive surgical procedures

"The hospitals & surgical centers segment is expected to have the largest share of the market in 2017."

In 2017, on the basis of end user, the hospitals and surgical centers segment is expected to account for the largest share of the market. The large share of this segment is attributed to increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, rising incidence of chronic vascular diseases, and growing availability of healthcare reimbursements across major countries.

"Asia Pacific is expected to register the highest growth rate during the forecast period."

Geographically, the atherectomy devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC atherectomy devices market can be attributed to the factors such as the presence of increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems.

Breakdown of supply-side primary interviews: by company type, designation, and region:

  • By Company Type - Tier 1 - 25%, Tier 2 - 30% and Tier 3 - 45%
  • By Designation - C level - 26%, Director level - 30%, Others - 44%
  • By Region - North America - 34%, Europe - 26%, APAC - 23%, RoW - 17%

The global atherectomy devices market is competitive, with a large number of global and local players. In 2016, the market was dominated by Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Product launches, strategic acquisitions, agreements & collaborations were the major strategies adopted by market players to achieve growth in the market.

Research Coverage:

This report studies the atherectomy devices market based on product, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis-industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the atherectomy devices market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the major players in the atherectomy devices market. The report analyzes the atherectomy devices market based on product, application, end user, and region
  • Product Development: Detailed insights on the research and development activities and product launches in the atherectomy devices market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various atherectomy devices across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the atherectomy devices market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the atherectomy devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. OPPORTUNITY INDICATORS
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. RESEARCH ASSUMPTIONS
  • 2.6. RESEARCH LIMITATIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATHERECTOMY DEVICES MARKET SNAPSHOT
  • 4.2. REGIONAL ANALYSIS: ATHERECTOMY DEVICES MARKET SIZE, BY PRODUCT (2017 VS. 2022)
  • 4.3. REGIONAL ANALYSIS: ATHERECTOMY DEVICES MARKET, BY APPLICATION
  • 4.4. APAC: ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION & COUNTRY, 2017
  • 4.5. GEOGRAPHIC ANALYSIS: ATHERECTOMY DEVICES MARKET, BY COUNTRY (2017-2022)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing target patient population
      • 5.2.1.2. Continuous product development and commercialization
      • 5.2.1.3. Favorable medical reimbursement scenario in mature markets
      • 5.2.1.4. Rising demand for minimally invasive surgical procedures
      • 5.2.1.5. Strengthening distribution channels of major product manufacturers
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Limited patient awareness related to disease diagnosis
      • 5.2.2.2. Stringent regulatory scenario
      • 5.2.2.3. Dearth of skilled and well-trained surgeons
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increasing number of research activities in the field of atherectomy
      • 5.2.3.2. Increasing healthcare expenditure across emerging markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Significant adoption of alternative therapies
  • 5.3. RESEARCH PIPELINE ANALYSIS
    • 5.3.1. DIRECTIONAL ATHERECTOMY
    • 5.3.2. PHOTO-ABLATIVE/LASER ATHERECTOMY
    • 5.3.3. ORBITAL ATHERECTOMY
    • 5.3.4. ROTATIONAL ATHERECTOMY

6. GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. DIRECTIONAL ATHERECTOMY DEVICES
  • 6.3. ORBITAL ATHERECTOMY DEVICES
  • 6.4. PHOTO-ABLATIVE (LASER) ATHERECTOMY DEVICES
  • 6.5. ROTATIONAL ATHERECTOMY DEVICES
  • 6.6. SUPPORT DEVICES

7. GLOBAL ATHERECTOMY DEVICES MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. PERIPHERAL VASCULAR APPLICATIONS
  • 7.3. CARDIOVASCULAR APPLICATIONS
  • 7.4. NEUROVASCULAR APPLICATIONS

8. GLOBAL ATHERECTOMY DEVICES MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS & SURGICAL CENTERS
  • 8.3. AMBULATORY CARE CENTERS
  • 8.4. RESEARCH LABORATORIES & ACADEMIC INSTITUTES

9. ATHERECTOMY DEVICES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. UK
    • 9.3.4. REST OF EUROPE
  • 9.4. ASIA PACIFIC
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA PACIFIC
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS, 2016
  • 10.3. COMPETITIVE SCENARIO AND TRENDS
    • 10.3.1. PRODUCT LAUNCHES AND ENHANCEMENTS
    • 10.3.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.3.3. EXPANSIONS
    • 10.3.4. MERGERS & ACQUISITIONS
    • 10.3.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES (Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*

  • 11.1. INTRODUCTION
  • 11.2. KONINKLIJKE PHILIPS
  • 11.3. MEDTRONIC
  • 11.4. CARDIOVASCULAR SYSTEMS
  • 11.5. BOSTON SCIENTIFIC
  • 11.6. C.R. BARD
  • 11.7. CARDINAL HEALTH
  • 11.8. MINNETRONIX, INC.
  • 11.9. AVINGER
  • 11.10. STRAUB MEDICAL
  • 11.11. BIOMERICS
  • 11.12. BIOTRONIK
  • 11.13. RA MEDICAL SYSTEMS
  • 11.14. TERUMO CORPORATION
  • 11.15. ABBOTT LABORATORIES
  • 11.16. B. BRAUN GROUP

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: IMPACT ANALYSIS: KEY MACROINDICATORS FOR THE ATHERECTOMY DEVICES MARKET, 2016
  • TABLE 2: MEDICAL REIMBURSEMENTS FOR ATHERECTOMY PROCEDURES
  • TABLE 3: DIRECTIONAL ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
  • TABLE 4: PHOTO-ABLATIVE/LASER ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
  • TABLE 5: ORBITAL ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
  • TABLE 6: ROTATIONAL ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
  • TABLE 7: GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 8: DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: NORTH AMERICA DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 10: EUROPE DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: ASIA PACIFIC DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 12: ORBITAL ATHERECTOMY DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: NORTH AMERICA ORBITAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: EUROPE ORBITAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: ASIA PACIFIC ORBITAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 16: PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: NORTH AMERICA PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 18: EUROPE PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: ASIA PACIFIC PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: ROTATIONAL ATHERECTOMY DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: NORTH AMERICA ROTATIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 22: EUROPE ROTATIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: ASIA PACIFIC ROTATIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: ATHERECTOMY DEVICES MARKET FOR SUPPORT DEVICES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: NORTH AMERICA SUPPORT DEVICES ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 26: EUROPE SUPPORT DEVICES ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 27: ASIA PACIFIC SUPPORT DEVICES ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 28: GLOBAL ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 29: ATHERECTOMY DEVICES MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: ATHERECTOMY DEVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: ATHERECTOMY DEVICES MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: GLOBAL ATHERECTOMY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 33: ATHERECTOMY DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 34: ATHERECTOMY PROCEDURAL COST: OFFICE-BASED LABS VS. AMBULATORY CARE CENTERS, 2016
  • TABLE 35: ATHERECTOMY DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: ATHERECTOMY DEVICES MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: ATHERECTOMY DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 39: NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 40: NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 42: US: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 43: US: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 44: CANADA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 45: CANADA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 46: EUROPE: ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 47: EUROPE: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 49: EUROPE: ATHERECTOMY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 50: GERMANY: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 51: GERMANY: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 52: FRANCE: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 53: FRANCE: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 54: UK: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 55: UK: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 56: ROE: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 57: ROE: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 58: ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 59: ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 62: JAPAN: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 63: JAPAN: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 64: CHINA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 65: CHINA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 66: INDIA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 67: INDIA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 68: ROAPAC: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 69: ROAPAC: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 70: ROW: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 71: ROW: ATHERECTOMY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 72: ROW: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 73: MAJOR PRODUCT LAUNCHES AND ENHANCEMENTS (2014-2017)
  • TABLE 74: MAJOR AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014-2017)
  • TABLE 75: MAJOR EXPANSIONS (2014-2017)
  • TABLE 76: MAJOR MERGERS & ACQUISITIONS (2014-2017)
  • TABLE 77: MAJOR OTHER DEVELOPMENTS (2014-2017)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARIES: ATHERECTOMY DEVICES MARKET
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION
  • FIGURE 6: DIRECTIONAL ATHERECTOMY IS ESTIMATED TO BE HOLD THE LARGEST SHARE IN ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 7: DIRECTIONAL ATHERECTOMY IS ESTIMATED TO HOLD THE LARGEST SHARE IN ATHERECTOMY DEVICES PRODUCT MARKET DURING THE FORECAST PERIOD
  • FIGURE 8: HOSPITALS & SURGICAL CENTERS IS ESTIMATED TO HOLD THE LARGEST SHARE IN ATHERECTOMY DEVICES END USER MARKET DURING THE FORECAST PERIOD
  • FIGURE 9: NORTH AMERICA TO DOMINATE THE GLOBAL ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 10: GROWING TARGET PATIENT POPULATION TO PROPEL THE DEMAND FOR ATHERECTOMY DEVICES DURING THE FORECAST PERIOD
  • FIGURE 11: DIRECTIONAL ATHERECTOMY DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE ATHERECTOMY DEVICES MARKET ACROSS ALL REGIONS IN 2022
  • FIGURE 12: NORTH AMERICA DOMINATED THE ATHERECTOMY DEVICES MARKET FOR ALL APPLICATION SEGMENTS IN 2017
  • FIGURE 13: PERIPHERAL VASCULAR APPLICATION WILL DOMINATE THE ASIA PACIFIC ATHERECTOMY DEVICES APPLICATION MARKET IN 2017
  • FIGURE 14: CHINA & INDIA ESTIMATED TO BE THE FASTEST-GROWING COUNTRIES IN THE GLOBAL ATHERECTOMY DEVICES MARKET
  • FIGURE 15: ATHERECTOMY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: PROPORTION OF GERIATRIC POPULATION: BY COUNTRY (2012 VS. 2020)
  • FIGURE 17: ONGOING CLINICAL TRIALS ACROSS THE GLOBE (AS OF SEPTEMBER 2016)
  • FIGURE 18: GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING COUNTRIES (2010 VS. 2015)
  • FIGURE 19: ANGIOPLASTY PROCEDURE COSTS ACROSS MAJOR COUNTRIES, 2016
  • FIGURE 20: INCIDENCE OF ANGIOPLASTY PROCEDURES ACROSS MAJOR EUROPEAN COUNTRIES (2009 VS. 2014)
  • FIGURE 21: DIRECTIONAL ATHERECTOMY DEVICES SEGMENT TO WITNESS HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 22: NORTH AMERICA TO HOLD LARGEST SHARE OF THE DIRECTIONAL ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: PERIPHERAL VASCULAR APPLICATIONS SEGMENT TO DOMINATE THE ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: NORTH AMERICA TO HOLD LARGEST SHARE OF THE PERIPHERAL VASCULAR APPLICATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 25: HOSPITALS & SURGICAL CENTERS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 26: NORTH AMERICA TO HOLD LARGEST SHARE OF THE HOSPITALS & SURGICAL CENTERS MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: NORTH AMERICA: ATHERECTOMY DEVICES MARKET SNAPSHOT (2017-2022)
  • FIGURE 28: EUROPE: ATHERECTOMY DEVICES MARKET SNAPSHOT
  • FIGURE 29: ASIA PACIFIC: ATHERECTOMY DEVICES MARKET SNAPSHOT
  • FIGURE 30: ROW: ATHERECTOMY DEVICES MARKET SNAPSHOT
  • FIGURE 31: KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE ATHERECTOMY DEVICES MARKET, 2014-2017
  • FIGURE 32: GLOBAL ATHERECTOMY DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
  • FIGURE 33: KONINKLIJKE PHILIPS: COMPANY SNAPSHOT
  • FIGURE 34: KONINKLIJKE PHILIPS: SWOT ANALYSIS
  • FIGURE 35: MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 36: MEDTRONIC: SWOT ANALYSIS
  • FIGURE 37: CARDIOVASCULAR SYSTEMS: COMPANY SNAPSHOT
  • FIGURE 38: CARDIOVASCULAR SYSTEMS: SWOT ANALYSIS
  • FIGURE 39: BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 40: BOSTON SCIENTIFIC: SWOT ANALYSIS
  • FIGURE 41: C.R.BARD: COMPANY SNAPSHOT
  • FIGURE 42: C.R.BARD: SWOT ANALYSIS
  • FIGURE 43: CARDINAL HEALTH: COMPANY SNAPSHOT
  • FIGURE 44: AVINGER: COMPANY SNAPSHOT
  • FIGURE 45: TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 46: ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 47: B. BRAUN GROUP: COMPANY SNAPSHOT
Back to Top